ABM/P-15 modulates proliferation and mRNA synthesis of growth factors of periodontal ligament cells

Acta Odontol Scand. 2009;67(2):65-73. doi: 10.1080/00016350802555525.

Abstract

Objective: Periodontal regeneration is histologically defined as regeneration of the tooth supporting structures, including alveolar bone, periodontal ligament, and cementum. Cells in the remaining periodontal tissues need optimal conditions if they are to perform their functions in the regeneration process. The present study is an investigation of the molecular effects of ABM/P-15 on human periodontal ligament cells (PDL) in vitro.

Material and methods: PDL cells obtained from healthy subjects were used for in vitro experiments. Cell proliferation, morphology, and mineralization using Von kossa staining were evaluated. mRNA expressions for transforming growth factor-beta (TGF-beta), insulin-like growth factor-I (IGF-I), basic fibroblast growth factor (b-FGF), vascular endothelial growth factor (VEGF), bone morphogenic protein-2 (BMP-2), platelet-derived growth factor (PDGF), and type 1 collagen (COL1) were assessed on days 3 and 7 using RT-PCR.

Results: ABM/P-15 enhanced proliferation of cultured PDL cells. It increased the mRNA expression of TGF-beta and BMP-2 in cultured PDL cells on days 3 and 7. IGF-I and b-FGF mRNA expressions showed a slight decrease, while PDGF expression was observed to have increased on day 3. VEGF and COL1 mRNA expressions were found not to be different on days 3 and 7. No differences were observed in the mineralization properties of cultured PDL cells treated with or without ABM/P-15.

Conclusions: Based on the results of this in vitro study, it may be concluded that ABM/P-15 enhanced the regenerative capacity of PDL by regulating specific gene expressions of cells during early wound healing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Matrix
  • Bone Morphogenetic Protein 2 / drug effects
  • Bone Morphogenetic Protein 2 / genetics
  • Bone Morphogenetic Protein 2 / metabolism
  • Bone Substitutes / pharmacology*
  • Cattle
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Collagen / pharmacology*
  • Collagen Type I / drug effects
  • Collagen Type I / genetics
  • Collagen Type I / metabolism
  • Drug Combinations
  • Fibroblast Growth Factor 2 / drug effects
  • Fibroblast Growth Factor 2 / genetics
  • Fibroblast Growth Factor 2 / metabolism
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology
  • Guided Tissue Regeneration, Periodontal / methods*
  • Humans
  • Hydroxyapatites / pharmacology*
  • Insulin-Like Growth Factor I / drug effects
  • Insulin-Like Growth Factor I / genetics
  • Insulin-Like Growth Factor I / metabolism
  • Intercellular Signaling Peptides and Proteins / genetics
  • Intercellular Signaling Peptides and Proteins / metabolism*
  • Peptide Fragments / pharmacology*
  • Periodontal Ligament / cytology
  • Periodontal Ligament / drug effects
  • Periodontal Ligament / metabolism*
  • Platelet-Derived Growth Factor / drug effects
  • Platelet-Derived Growth Factor / genetics
  • Platelet-Derived Growth Factor / metabolism
  • RNA, Messenger / analysis
  • Reference Values
  • Tissue Scaffolds
  • Transforming Growth Factor beta / drug effects
  • Transforming Growth Factor beta / genetics
  • Transforming Growth Factor beta / metabolism
  • Vascular Endothelial Growth Factors / drug effects
  • Vascular Endothelial Growth Factors / genetics
  • Vascular Endothelial Growth Factors / metabolism

Substances

  • Bone Morphogenetic Protein 2
  • Bone Substitutes
  • Collagen Type I
  • Drug Combinations
  • Hydroxyapatites
  • Intercellular Signaling Peptides and Proteins
  • Peptide Fragments
  • Platelet-Derived Growth Factor
  • RNA, Messenger
  • Transforming Growth Factor beta
  • Vascular Endothelial Growth Factors
  • cell-binding peptide P-15
  • Fibroblast Growth Factor 2
  • Insulin-Like Growth Factor I
  • Collagen